Clinical Trial Update: Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 [Phase 1]

View source ↗

Summary

This is a Phase 1 single-dose escalation trial of GSK3050002 to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics in ulcerative colitis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GSK3050002

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colitis, Ulcerative | Phase 1 | Status: COMPLETED